NEW YORK (GenomeWeb News) – Months removed from the commercial launch of its first test, Theranostics Health is targeting reimbursements as it looks to build a revenue stream for the test.

The Rockville, Md.-based firm launched the TheraLink HER Family Assay at the American Society of Clinical Oncology annual meeting in June, marking the next chapter in Theranostics' commercial build-out.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.